FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…
Brain cells can harbor and spread HIV virus to the body
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
WHO reported cluster of COVID-19 in Beijing, China
On Jun. 11, 2020, the World Trade Organizationï¾’s (WTO) reported that it was following up with Chinese authorities…
Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
COVID-19 mouse model announced to speed search for drugs, vaccines
On Jun. 10, 2020, Washington University School of Medicine in St. Louis reported they had developed a mouse…
OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia
On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…
Largest catalog of human genetic diversity released
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test
On Jun. 9, 2020, Illumina announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…
Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay
On Jun. 9, 2020, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the FDA,…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Therapeutics
NIH researchers uncovered genes linked to common recurrent fever in children
On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…
Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergy
On Jun. 8, 2020, Aimmune Therapeutics announced two-year data that suggested long-term efficacy of daily treatment with PALFORZIA…
OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
Biotechnology | HIV | Life Science News | NIH
Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIV
On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an…
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro
On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…
University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
WHO welcomed crucial new funding for vaccines
On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…
AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
Gilead announced results from phase 3 trial of Remdesivir in patients with moderate COVID-19
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
SIGA announced first international delivery of Oral TPOXX
On Jun. 1, 2020, SIGA Technologies announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Non-Profit Research | Therapeutics | Vaccine
International community rallied to support open research and science to fight COVID-19
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…